Cynata Therapeutics Limited (OTCPK:CYYNF) Investor Webinar Conference Call February 5, 2025 6:30 PM ET
Company Participants
Lauren Nowak – Media Relations
Kilian Kelly – Chief Executive Officer and Managing Director
Mathias Kroll – Chief Business Officer
Geoff Brooke – Independent Non-Executive Chairman
Conference Call Participants
Lauren Nowak
Okay. Great. Let’s get going. Good morning, everyone, and thank you for joining. Welcome to the first Cynata Therapeutics Investor Webinar of the year. Presenting this morning will be CEO, Dr. Kilian Kelly; and Chief Business Officer, Dr. Mathias Kroll, who will take you through activity and highlights for the quarter ending December 2024, and then we’ll have time for questions at the end of the presentation. Dr. Geoff Brooke, Cynata’s Chair, is not on the line today as he is currently traveling overseas. If you’d like to ask a question, please use the Q&A button at the bottom of your screen, you can submit these anytime. But we will hold all of the questions until the end of the call.
And lastly, just as a reminder, this call is being recorded and will be available on the company website in the coming days.
I’ll now hand over to Kilian to formally commence the presentation.
Kilian Kelly
Thanks very much, Lauren, and good morning to everybody, and thanks for joining today. So as usual, we’ll keep the presentation relatively brief, so we have time for questions and answers at the end. So as everybody will be aware, we completed a financing during the last quarter. And there have been some changes to the largest shareholders in terms of percentage, not in terms of any selling of the shares, but we’re still in the same position where we have our three largest shareholders who are Bioscience Managers, Fidelity International and Fujifilm. The market cap of the company is now just a bit over $55 million.
Read the full article here
